Efforts to develop a consensus definition are ongoing and will greatly facilitate the
development and testing of novel interventions for sarcopenia. Although pharmaceutical …

Life expectancy is increasing worldwide, with a resultant increase in the elderly population.
Aging is characterized by the progressive loss of skeletal muscle mass and strength–a …

Sarcopenia is a condition that is characterized by loss of muscle mass, muscle strength and
muscle functional impairment with ageing. The definition of sarcopenia has been through …

Sarcopenia is the age-related loss of muscle mass and strength. It has been receiving
international attention because of its increased prevalence in western societies, such as …

Musculoskeletal ageing is a major public health concern owing to demographic shifts in the
population. Sarcopenia, generally defined as the age-related loss of muscle mass and …

Sarcopenia, defined as a syndrome rather than as a pathology, is the loss of muscle mass
and function associated with age. Sarcopenia is an enigma for medicine, and despite the …

Background Sarcopenia is increasingly recognized as a correlate of ageing and is
associated with increased likelihood of adverse outcomes including falls, fractures, frailty …

Sarcopenia, the age-dependent loss of muscle mass and function, is a common condition
among older adults, and is associated with several adverse health outcomes. Owing to the …

Sarcopenia refers to age‐associated decrease in muscle mass and function. The condition
was originally described in the elderly, but emerging evidence suggests that it is also a …

Sarcopenia is a skeletal muscle disorder that commonly occurs with advancing age as well
as with a number of long-term conditions. Recognition in clinical practice is relatively recent …